Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

UNIPROTKB.ISOFORM:P27930-1 CUI (Isoform)

Uniprotkb Isoform:P27930-1

Id:5a0c2386-3174-59d4-9808-c84c56e0671f

Results found

Linked to

	Label	Description
	GLYCOPROTEIN:P27930-1-6 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-8 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	Interleukin-1 receptor type 2 has isoform UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-11 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-7 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-5 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-12 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-10 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-4 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOPROTEIN:P27930-1-1 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-6 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-8 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

Interleukin-1 receptor type 2 has isoform UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-11 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-7 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-5 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-12 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-10 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-4 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOPROTEIN:P27930-1-1 CUI sequence UNIPROTKB.ISOFORM:P27930-1 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.